BD Announces Results for Third Fisc...(7.3 TOTAL REVENUES $1867587 ...),Health

TOTAL REVENUES $1,867,587 $1,631,159 14.5 7.6 6.9

(1) Cell Analysis consists of the Immunocytometry Systems and the

Pharmingen units that were previously reported separately.

BECTON DICKINSON AND COMPANY

SUPPLEMENTAL REVENUE INFORMATION

REVENUES BY BUSINESS SEGMENTS AND UNITS

Nine Months Ended June 30,

(Unaudited; Amounts in thousands)

United States

2008 2007 % Change

BD MEDICAL

Medical Surgical

Systems $729,152 $711,545 2.5

Diabetes Care 298,071 280,255 6.4

Pharmaceutical

Systems 151,882 135,961 11.7

Ophthalmic Systems 18,584 18,382 1.1

TOTAL $1,197,689 $1,146,143 4.5

BD DIAGNOSTICS

Preanalytical

Systems $428,391 $403,211 6.2

Diagnostic Systems 412,304 378,433 9.0

TOTAL $840,695 $781,644 7.6

BD BIOSCIENCES

Cell Analysis (1) $225,814 $205,237 10.0

Discovery Labware 108,077 109,705 (1.5)

TOTAL $333,891 $314,942 6.0

TOTAL UNITED STATES $2,372,275 $2,242,729 5.8

(1) Cell Analysis consists of the Immunocytometry Systems and the

Pharmingen units that were previously reported separately.

BECTON DICKINSON AND COMPANY

SUPPLEMENTAL REVENUE INFORMATION

REVENUES BY BUSINESS SEGMENTS AND UNITS

Nine Months Ended June 30, (continued)

(Unaudited; Amounts in thousands)

International

% Change

2008 2007 Reported FX Neutral FX Impact

'/>"/>